VI
IRWD icon

Vestcor Inc’s Ironwood Pharmaceuticals IRWD Stock Holding History

Vestcor Inc’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-148,614
Closed -$658K – 1221
2024
Q4 		$658K Sell
148,614
-10,852
-7% -$44K 0.02% 581
2024
Q3 		$657K Buy
159,466
+43,703
+38% +$235K 0.02% 594
2024
Q2 		$755K Buy
115,763
+104,136
+896% +$737K 0.03% 512
2024
Q1 		$101K Hold
11,627
– – ﹤0.01% 1093
2023
Q4 		$133K Hold
11,627
– – ﹤0.01% 1058
2023
Q3 		$112K Buy
+11,627
New +$114K ﹤0.01% 1101

Other funds holding IRWD

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Vestcor Inc's IRWD Position: Q1 2025 in Review

Vestcor Inc sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2025, closing a stake of 148,614 shares — an estimated $658K sold.

Vestcor Inc first reported a position in IRWD in Q3 2023 and held it in 6 quarters. The position peaked at $755K in Q2 2024. 200 funds tracked by Wall St. Rank hold IRWD as of Q1 2025.

  • Vestcor Inc reported no remaining Ironwood Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Vestcor Inc sold 148,614 Ironwood Pharmaceuticals shares in Q1 2025, an estimated $658K.
  • Vestcor Inc first reported a position in Ironwood Pharmaceuticals in Q3 2023 and held it in 6 quarters.
  • Vestcor Inc's Ironwood Pharmaceuticals position peaked at $755K in Q2 2024.
  • 200 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2025.

Based on Vestcor Inc's 13F filing for Q1 2025, filed 8 May 2025.